about
Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys.Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertAssociation of renal damage with cardiovascular diseases is independent of individual cardiovascular risk profile in hypertension: data from the Italy - Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease stuBlood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension.Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.An analysis of the management of cardiovascular risk factors in routine clinical practice in Italy: an overview of the main findings of the EFFECTUS study.Hypertension in premenopausal women: is there any difference?Calcium channel blockers and hypertension.Prevalence of 'borderline' values of cardiovascular risk factors in the clinical practice of general medicine in Italy: results of the BORDERLINE study.Attitudes and preferences for the clinical management of patients with hypertension and hypertension with chronic obstructive pulmonary disease in Italy: main results of a survey questionnaire.Impact of hypertension on global cardiovascular risk stratification: analysis of a large cohort of outpatient population in Italy.Nocturnal headache-hypertension syndrome: a chronobiologic disorder.Do diabetes, metabolic syndrome or their association equally affect biventricular function? A tissue Doppler study.Abnormal regulation of renin angiotensin aldosterone system is associated with right ventricular dysfunction in hypertension.Synergic effect of high renin and aldosterone levels on inappropriate left ventricular mass and systolic function: a tissue Doppler study.Impact of physicians' age on the clinical management of global cardiovascular risk: analysis of the results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitisation Educational Programme.Preclinical effects of healthy obesity on inappropriate left ventricular mass and systolic function.Management of hypertension and stroke prevention: results of the Italian cardiologist survey.Synergic effects of renin and aldosterone on right ventricular function in hypertension: a tissue Doppler study.Early cardiac abnormalities and increased C-reactive protein levels in a cohort of children with sleep disordered breathing.Impact of diabetes mellitus on the clinical management of global cardiovascular risk: analysis of the results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitization (EFFECTUS) educational program.A Novel Electrocardiographic T-Wave Measurement (Tp-Te Interval) as a Predictor of Heart Abnormalities in Hypertension: A New Opportunity for First-Line Electrocardiographic Evaluation.The amount of monitoring time required in determining a blood pressure profile. The way we used to reduce artifacts influence.Clinical management of patients with hypertension and high cardiovascular risk in specialised centers and in general practice. Analysis from an Italian Survey QuestionnaireAttitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart SurveyEvaluation of Systolic Properties in Hypertensive Patients With Different Degrees of Diastolic Dysfunction and Normal Ejection FractionMarkers of Inflammation and Fibrosis Are Related to Cardiovascular Damage in Hypertensive Patients with Metabolic SyndromeReduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular massAn atypical clinical presentation of renovascular hypertensionGlobal cardiovascular risk management in different Italian regions: An analysis of the evaluation of final feasible effect of control training and ultra sensitisation (EFFECTUS) educational programAngiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical TrialsHigh blood pressure, ventricular tachycardia and transient left ventricular dysfunction: do not forget pheocromocytomaInadequate RAAS suppression is associated with excessive left ventricular mass and systo-diastolic dysfunction
P50
Q30891449-2091A664-0360-414A-9C77-3BF614501DDFQ33410472-F529C120-CB2D-4207-A4E3-07E801CB2C3DQ33509278-9251F869-4725-411C-84F6-D9F28DE69666Q34264074-FA182D3D-190F-4DC9-9254-6ED2E66C23C4Q37390740-68CC47B7-D06D-4C7E-8689-7514B97B627BQ37879657-4951263A-32CF-4DA5-90D3-35DAEE2648FAQ38201665-9C2A1CC0-C4C9-4903-95DD-042381534173Q38268367-45121ADF-8343-4772-A520-A6110512F0BCQ39722466-75CADAFB-C222-4DD6-83EF-93D7DEA8E9E0Q40926923-39132B63-E726-4605-8AA4-07847748CF20Q41519456-F0D9A9CF-84D2-4253-833B-BD4C4B021F90Q43693280-7B435F17-F850-4634-A607-9D94D43DF02AQ43779843-2BEA0B92-A272-46E9-B193-855DFFDBC2D8Q44350704-B0E49801-B1B4-4862-8F98-930B37D0216CQ44553228-27A210FE-61E9-4712-9FA0-555EB81C7A65Q44774947-39E1F0EE-3AA4-43B1-8CFD-4E7377D18D15Q46007167-2DC52995-A006-4ECA-A9F1-7C3CB3EBB2E2Q46437037-FD715B69-0552-4D21-A1DF-6ED91C6D047CQ46882535-78B82115-4A19-4543-B9D6-C4B228C1417AQ48323175-C14DA8F1-0FC2-4897-B5C5-FB41D60DEF39Q51416050-D5920794-B200-4B0F-8736-A33F4CA1F53DQ53578140-D92213B4-F56E-4E3A-BB06-D31F7F0618D0Q54209633-EEBC09ED-8FFE-4524-BD12-4080C4527265Q56968822-43830896-8396-415B-8D21-043B11DBC9F4Q56969474-BB31F4B5-37E0-4476-8ADC-3A0BD2F1CEAAQ61783471-AB6F5F3F-FC97-4233-9981-1D66E9C540DFQ61783475-1F68C218-5189-4B50-A236-B7AB2D19529BQ61783477-A2159A8A-A5FF-4246-9897-30D5A1747C0AQ61865887-2DD21E47-3960-4782-9ABA-491A3549B00CQ61866075-38CBFE09-1370-471F-B4AB-A37C28299B6DQ61866091-B18A440C-52DD-4135-B24D-8C99E8FBC952Q84631935-65805C18-ADA3-479D-9D7D-C49C3214962CQ86949330-8C7223B9-9975-4533-B7D9-BCABE3A668E8
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrea Ferrucci
@ast
Andrea Ferrucci
@en
Andrea Ferrucci
@es
Andrea Ferrucci
@nl
Andrea Ferrucci
@sl
type
label
Andrea Ferrucci
@ast
Andrea Ferrucci
@en
Andrea Ferrucci
@es
Andrea Ferrucci
@nl
Andrea Ferrucci
@sl
prefLabel
Andrea Ferrucci
@ast
Andrea Ferrucci
@en
Andrea Ferrucci
@es
Andrea Ferrucci
@nl
Andrea Ferrucci
@sl
P106
P1153
6602090811
P31
P496
0000-0002-5923-9310